bf/NASDAQ:MEIP_icon.jpeg

COM:MEIPHARMA

MEI Pharma

  • Stock

Last Close

2.80

21/11 21:00

Market Cap

18.59M

Beta: -

Volume Today

18.87K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    meipharma.com
  • ipo date

    Dec 18, 2003

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib mult...Show More

peer of